Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
That drug is actually both a GLP-1 and a GIP receptor agonist
Kaihara, K
The participants in the highest loop diuretic dose category lost 6.9% of their body weight on average
Orforglipron (LY3502970) is a non-peptide GLP-1R agonist currently in clinical development that has demonstrated promising effects on glycemic control and body weight reduction, highlighting the continued expansion of GLP-1-based therapeutic strategies [4]
PTs, Preferred Terms
US$ 24.84
US$ 21.02
US$ 20.71
US$ 25.75
